These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 33096096)

  • 1. Development and characterization of Brigatinib loaded solid lipid nanoparticles: In-vitro cytotoxicity against human carcinoma A549 lung cell lines.
    Ahmed MM; Fatima F; Anwer MK; Aldawsari MF; Alsaidan YSM; Alfaiz SA; Haque A; Az A; Alhazzani K
    Chem Phys Lipids; 2020 Nov; 233():105003. PubMed ID: 33096096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brigatinib loaded poly(d,l-lactide-co-glycolide) nanoparticles for improved anti-tumoral activity against non-small cell lung cancer cell lines.
    Ahmed MM; Fatima F; Anwer MK; Aldawsari MF; Bhatia S; Al-Harrasi A
    Drug Dev Ind Pharm; 2021 Jul; 47(7):1112-1120. PubMed ID: 34551665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
    Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
    Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line.
    Bhatt H; Rompicharla SVK; Komanduri N; Aashma S; Paradkar S; Ghosh B; Biswas S
    Curr Drug Deliv; 2018; 15(9):1271-1283. PubMed ID: 29732970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Perphenazine-Loaded Solid Lipid Nanoparticles: Statistical Optimization and Cytotoxicity Studies.
    Farsani PA; Mahjub R; Mohammadi M; Oliaei SS; Mahboobian MM
    Biomed Res Int; 2021; 2021():6619195. PubMed ID: 33997026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Domperidone Solid Lipid Nanoparticles: In Vitro and In Vivo Characterization.
    Shazly GA; Alshehri S; Ibrahim MA; Tawfeek HM; Razik JA; Hassan YA; Shakeel F
    AAPS PharmSciTech; 2018 May; 19(4):1712-1719. PubMed ID: 29532427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and investigation of indirubin-loaded SLN nanoparticles and their anti-cancer effects on human glioblastoma U87MG cells.
    Rahiminejad A; Dinarvand R; Johari B; Nodooshan SJ; Rashti A; Rismani E; Mahdaviani P; Saltanatpour Z; Rahiminejad S; Raigani M; Khosravani M
    Cell Biol Int; 2019 Jan; 43(1):2-11. PubMed ID: 30080277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Praziquantel-Solid Lipid Nanoparticles Produced by Supercritical Carbon Dioxide Extraction: Physicochemical Characterization, Release Profile, and Cytotoxicity.
    Andrade LN; Oliveira DML; Chaud MV; Alves TFR; Nery M; da Silva CF; Gonsalves JKC; Nunes RS; Corrêa CB; Amaral RG; Sanchez-Lopez E; Souto EB; Severino P
    Molecules; 2019 Oct; 24(21):. PubMed ID: 31661906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation, physicochemical characterization, and anti-proliferative properties of Lawsone-loaded solid lipid nanoparticles.
    Rasouliyan F; Eskandani M; Jaymand M; Akbari Nakhjavani S; Farahzadi R; Vandghanooni S; Eskandani M
    Chem Phys Lipids; 2021 Sep; 239():105123. PubMed ID: 34403685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and statistical modeling of mannose-decorated dapsone-containing nanoparticles as a strategy of targeting intestinal M-cells.
    Vieira AC; Chaves LL; Pinheiro M; Ferreira D; Sarmento B; Reis S
    Int J Nanomedicine; 2016; 11():2601-17. PubMed ID: 27354792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation, optimization, and
    Nasiri F; Faghfouri L; Hamidi M
    Drug Dev Ind Pharm; 2020 Jan; 46(1):159-171. PubMed ID: 31894713
    [No Abstract]   [Full Text] [Related]  

  • 12. Marrubiin-loaded solid lipid nanoparticles' impact on TNF-α treated umbilical vein endothelial cells: A study for cardioprotective effect.
    Nakhlband A; Eskandani M; Saeedi N; Ghafari S; Omidi Y; Barar J; Garjani A
    Colloids Surf B Biointerfaces; 2018 Apr; 164():299-307. PubMed ID: 29413609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Isradipine Loaded Solid Lipid Nanoparticles on the Pharmacodynamic Effect in Rats.
    Thirupathi G; Swetha E; Narendar D
    Drug Res (Stuttg); 2017 Mar; 67(3):163-169. PubMed ID: 27992936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mannosylated solid lipid nanoparticles for lung-targeted delivery of Paclitaxel.
    Sahu PK; Mishra DK; Jain N; Rajoriya V; Jain AK
    Drug Dev Ind Pharm; 2015 Apr; 41(4):640-9. PubMed ID: 24564799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery.
    Jose S; Anju SS; Cinu TA; Aleykutty NA; Thomas S; Souto EB
    Int J Pharm; 2014 Oct; 474(1-2):6-13. PubMed ID: 25102112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-reporter shikonin-Act-loaded solid lipid nanoparticle: formulation, physicochemical characterization and geno/cytotoxicity evaluation.
    Eskandani M; Nazemiyeh H
    Eur J Pharm Sci; 2014 Aug; 59():49-57. PubMed ID: 24768857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel resveratrol smart lipids; design, formulation, and biological evaluation of anticancer activity.
    Diab RF; Abdelghany TM; Gad S; Elbakry AM
    J Pharm Pharmacol; 2024 Jun; 76(6):631-645. PubMed ID: 38507715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of retinoic acid to LNCap human prostate cancer cells using solid lipid nanoparticles.
    Akanda MH; Rai R; Slipper IJ; Chowdhry BZ; Lamprou D; Getti G; Douroumis D
    Int J Pharm; 2015 Sep; 493(1-2):161-71. PubMed ID: 26200751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact Of Penetratin Stereochemistry On The Oral Bioavailability Of Insulin-Loaded Solid Lipid Nanoparticles.
    Alsulays BB; Anwer MK; Soliman GA; Alshehri SM; Khafagy ES
    Int J Nanomedicine; 2019; 14():9127-9138. PubMed ID: 31819423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation of acyclovir-loaded solid lipid nanoparticles: design, optimization, and
    El-Gizawy SA; El-Maghraby GM; Hedaya AA
    Pharm Dev Technol; 2019 Dec; 24(10):1287-1298. PubMed ID: 31507232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.